TP53 and carcinoma: The ESPL1 hypomorphic, p53 heterozygous transgenic mice (ESPL1+/hyp, p53+/−) also show a significantly reduced life span with an altered tumor spectrum of carcinomas and sarcomas compared to p53+/− mice alone.